Search results
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 1 day agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
The Path to a Better Tuberculosis Vaccine Runs Through Montana
US News & World Report· 2 days agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people ...
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
Zacks· 1 week agoIn the United States, the vaccine is marketed as Novavax COVID-19 Vaccine, Adjuvanted. At the time ...
England Launches Latest Round Of Covid-19 Booster Vaccines
Forbes· 6 days agoEngland has launched its latest Covid-19 booster campaign for those at the highest risk from the...
How can companies address consumers who are averse to products using a novel technology?
Phys.org· 3 days agoThe study, which appears in the Journal of Marketing, is titled "Adoption of New Technology Vaccines...
4 Years In, a Sobering Look at Long COVID Progress
Medscape· 4 days agoFour years ago in the spring of 2020, physicians and patients coined the term "long COVID" to describe a form of the viral infection from which recovery...
COVID Vaccinations Less Prevalent in Marginalized Patients
Medscape· 5 days agoPrimary care physicians who served marginalized communities had the highest proportion of patients...
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
Zacks via Yahoo Finance· 1 week agoTo extend its existing cash runway and curb cash burn, Novavax (NVAX) initiates multiple...
Cincinnati COVID cases trending down, health department reports
Gannett via AOL· 5 days agoHere’s what you need to know. People aged 65 years or older who received a single dose of any COVID-19 vaccine from the 2023-24 season, including Pfizer-BioNTech, Moderna ...
COVID-19 On Steep Decline, But Physicians Advise Public To Continue Vaccines
Houston Press· 4 days ago“We expect it to continue to be like this for a few months,” said Dr. Luis Ostrosky, chief of infectious diseases and epidemiology at UTHealth Houston. Ostrosky said people have built up immunity ...